解郁柴胡疏肝汤联合黛力新治疗脑卒中后抑郁症30例

您当前的位置：

首页 >

文章列表页 >

解郁柴胡疏肝汤联合黛力新治疗脑卒中后抑郁症30例

更新时间：2021-11-17

- 解郁柴胡疏肝汤联合黛力新治疗脑卒中后抑郁症30例
- Journal of Traditional Chinese Medicine Vol. 50, Issue S1, Pages: 123(2009)
- 作者机构：
  
  河南省新郑市中医院
- 作者简介：
- 基金信息：
- DOI：
  CLC： R277.7
- Published：2009
- 稿件说明：
移动端阅览
[1]高志超.解郁柴胡疏肝汤联合黛力新治疗脑卒中后抑郁症30例[J].中医杂志,2009,50(S1):123.

解郁柴胡疏肝汤联合黛力新治疗脑卒中后抑郁症30例[J]. Journal of Traditional Chinese Medicine2009, 50(S1): 123.
[1]高志超.解郁柴胡疏肝汤联合黛力新治疗脑卒中后抑郁症30例[J].中医杂志,2009,50(S1):123. DOI：

解郁柴胡疏肝汤联合黛力新治疗脑卒中后抑郁症30例[J]. Journal of Traditional Chinese Medicine2009, 50(S1): 123. DOI：

摘要

<正>脑卒中后抑郁（PSD）是脑血管意外的常见并发症

抑郁的发生对患者的神经功能及日常生活能力有严重的影响

不利于卒中患者的康复

甚至增加脑血管病的病死率。2007年以来我院对PSD30例采用解郁柴胡疏肝汤联合黛力新治疗

取得较好疗效

现报告如下。

Abstract

<正>脑卒中后抑郁（PSD）是脑血管意外的常见并发症

抑郁的发生对患者的神经功能及日常生活能力有严重的影响

不利于卒中患者的康复

甚至增加脑血管病的病死率。2007年以来我院对PSD30例采用解郁柴胡疏肝汤联合黛力新治疗

取得较好疗效

现报告如下。

关键词

Keywords

references

查看原文

Views

111

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Efficacy and Economic Evaluation of 1293 Non-Severe Adult Patients with Community-Acquired Pneumonia Treated by the Jiangsu Traditional Chinese Medicine Diagnosis and Treatment Protocol for Dominant Diseases：A Multicenter，Retrospective Real-World Cohort Study

Challenges and Recommendations for Implementing Key Technologies in Decentralized Clinical Trials of Traditional Chinese Medicine

LI Guolie's Experience in Treating Orthostatic Hypotension from the Perspective of "Raising the Clear and Directing the Turbid Downward"

Similarities and Differences between Myofascial Trigger Points and Sinew Knot：from the Perspective of the Channel Sinew Theory

Research on the Correlation Between "Tiangui （天癸）" and Female Reproductive Genetic Diseases

Related Author

No data

Related Institution

No data

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰